menu

Quintiles Library

Show Filters
White Paper
Medical device makers are bullish about the future in general and about Asia-Pacific in particular. With a current commercial market size of USD $55 billion to $60 billion the region is a hot spot for medical device companies worldwide for sales, investment and expansion.  This paper looks at the factors behind the attractiveness of Asia-Pacific for medical device...
Explore More
Fact Sheet
Putting the right support in the right place at the right time in order to meet patients’ specific needs is the key challenge for the healthcare ecosystem. Our infographic highlights the drivers behind an increased emphasis on the provision of patient support and engagement. It shows why Biopharma, healthcare professionals and patients need to work together to build and...
Read More
Fact Sheet
The changing healthcare landscape poses significant challenges to the traditional, segmented biopharmaceutical product development model. Asset development has become increasingly complex as companies trying to optimize their ROI work to meet the value objectives and evidence needs of different stakeholders in order to optimize the return on their assets. Addressing these...
Read More
Presentation
Presentation by Dr. Birgit Friedmann, Head of Integrated Market Access DACH CEE, from IPLS Meeting 2015 on "Market Access Assessment as essential part of deal making". Dr. Friedmann assesses the potential gaps that need to be filled in order to achieve successful access for new products.
Explore More
Presentation
In this webinar, our speakers Jaclyn Bosco, PhD, MPH, Director, Epidemiology and Outcomes Research, Real World & Late Phase Research at Quintiles and Kamali Chance, MPH, PhD, RAC, Vice President, Head Global of Biosimilars Regulatory Strategy at Quintiles will cover regulatory pathways and legislation in the US and EU; stakeholders and uptake considerations and...
Explore More
Press Release
RESEARCH TRIANGLE PARK, N.C. – November 9, 2015 – Quintiles, the world’s largest biopharma services provider, has announced its contribution of enhancements to the ResearchKit framework which was designed by Apple to make it easy for researchers to gather data more frequently and more accurately from research participants using iPhone apps. ResearchKit enables...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C.– November 5, 2015 – Quintiles Founder Dr. Dennis Gillings, CBE, will retire from his position as Executive Chairman of Quintiles Transnational Holdings Inc. (NYSE: Q) at the end of this year, December 31, 2015. Dr. Gillings will remain on the Board as a director. The Board has appointed Jack M. Greenberg to serve as Chairman of the Board,...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – November 5, 2015 – Today, the Quintiles Transnational Holdings Inc. (the “Company”) Board of Directors increased the Company’s share repurchase authorization by $300 million for repurchase of the Company’s outstanding common stock. The share repurchase program does not obligate the Company to acquire any particular amount of common stock,...
Read More
Press Release
RESEARCH TRIANGLE PARK, NC - Quintiles CEO Tom Pike will present at the Credit Suisse 2015 Healthcare Conference on Tuesday, November 10, 2015 in Phoenix at the Phoenician resort. The Quintiles presentation will begin at 10:30 a.m. (MST). Investors may access a live audio webcast of the presentation on the Quintiles’ investor relations website at...
Read More
White Paper
Putting the right support in the right place at the right time in order to meet patients’ specific needs is the key challenge for the healthcare ecosystem. The increased emphasis on the provision of patient support and engagement is largely driven by ongoing changes in chronic disease prevalence, allied to shifts in company pipelines, an evolving regulatory and access...
Explore More
Press Release
RESEARCH TRIANGLE PARK, N.C. – October 30, 2015 – Quintiles, the world’s largest provider of product development and integrated healthcare services, today published new research that reveals high levels of patient satisfaction and engagement in clinical research. Based on a survey of U.S. clinical research patients, all of the respondents agreed that clinical research...
Read More
Fact Sheet
As they increasingly outsource to manage complexity and costs, medical device developers can trust Quintiles to help them seize opportunity in Asia Pacific.
Read More
Fact Sheet
Vaccines’ widespread use in healthy populations, including children, pregnant women and the elderly, establishes high societal requirements for effectiveness and product safety. As a result, vaccines require post-approval studies and surveillance activities to further monitor adverse effects between products or batches in near real time, as demonstrated by the European...
Read More
Presentation
Join Jennifer Christian, VP, Clinical Evidence, Scientific Affairs at Quintiles and David Thompson, Sr. VP, Advisory Services at Quintiles for a complimentary webinar as they discuss, enriched prospective study designs that leverage EMR data including randomized, pragmatic studies; study implementation considerations; and case studies.
Explore More
Press Release
Research Triangle Park, NC, October 28, 2015 – Quintiles Transnational Holdings Inc. (“Quintiles” or the “Company”) (NYSE: Q) today reported its financial results for the quarter ended September 30, 2015. 8.3% constant currency service revenue growth compared to the third quarter of 2014 44.6% increase in diluted adjusted EPS to $0.94 per share compared to the...
Read More
White Paper
Patient engagement and experience is increasingly recognized as a vital element in healthcare, and mounting evidence confirms the influence of patient engagement with improved outcomes and reduced costs. As a way to improve patient engagement, we feel that clinical research participation offers an innovative care option which supports the goals of the “triple aim” –...
Explore More
Article
While the number of clinical trials in this area has increased in recent years, there remains an urgent and unmet need for new therapies. This article aims to identify key methodological, practical, and ethical issues involved in IPF clinical trials, focusing on country and site identification, feasibility, and study design. Approaches for mitigating these challenges will...
Read More
White Paper
This paper examines the changing environment for marketed products, including an analysis of emerging markets, recent divestment discussions, challenges in the current model, and a proposed alternative view of how biopharmaceutical companies can maintain the licenses of their marketed products more cost effectively and thereby generate greater net returns. For information...
Explore More
Press Release
RESEARCH TRIANGLE PARK, NC and DANBURY, CT, October 22, 2015 – Quintiles and IMS Health today announced a global strategic alliance that will advance the way biopharmaceutical companies generate real-world evidence (RWE) and apply critical insights to drive late-stage clinical research. With complementary strengths in real-world data management, operational delivery,...
Read More
Article
Laura Marquis, VP and Global Head of Quintiles Emerging Biopharma Solution was interviewed by PartneringNews about Quintiles' new approach for small and emerging biopharma companies, tips for choosing the right CRO, and the benefits of being virtual.
Read More